Lv41
520 积分 2023-08-23 加入
Blocking IFNγ in CAR-T Reduces Checkpoint Inhibitors and Cell-Mediated Toxicity without Compromising Therapeutic Efficacy in CD19 +malignancies
4小时前
求助中
Enhancing CAR-T cell efficacy through IFN ablation
4小时前
待确认
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
9个月前
已完结
In vivo CAR engineering for immunotherapy
9个月前
已完结
皖公网安备34019202002308
